STAT+: As Humira biosimilars take over the market, CVS has created a new ploy: the drug ‘rebate credit’

As Humira biosimilars have taken over the market, CVS Caremark has created a new ploy to make money: the drug “rebate credit.”
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks